Iovance Biotherapeutics Inc. buy The Goldman Sachs Group, Inc.
Start price
12.05.25
/
50%
€1.71
Target price
12.05.26
€7.13
Performance (%)
28.52%
Price
10:32
€2.20
Summary
This prediction is currently active. The prediction currently has a performance of 28.52%. This prediction currently runs until 12.05.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Iovance Biotherapeutics Inc. | 10.609% | 10.609% |
| iShares Core DAX® | -1.212% | 1.925% |
| iShares Nasdaq 100 | -4.714% | -1.810% |
| iShares Nikkei 225® | -2.976% | -2.660% |
| iShares S&P 500 | -2.744% | -0.448% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Iovance Biotherapeutics Inc. diskutieren
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $16.00 to $8.00. They now have a "buy" rating on the stock.
Ratings data for IOVA provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€1.60
15.07.25
15.07.25
€0.86
15.07.26
15.07.26
31.66%
10:32
10:32
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€2.71
17.04.25
17.04.25
€14.08
17.04.26
17.04.26
-22.29%
10:32
10:32
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€3.90
03.03.25
03.03.25
€18.11
03.03.26
03.03.26
-43.62%
10:32
10:32
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€14.52
29.02.24
29.02.24
€19.38
28.02.25
28.02.25
-72.27%
01.03.25
01.03.25
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€11.80
20.02.24
20.02.24
€17.55
20.02.25
20.02.25
-53.22%
21.02.25
21.02.25
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€5.05
20.11.23
20.11.23
€10.98
20.11.24
20.11.24
53.15%
21.11.24
21.11.24